General Anesthesia

Correct Answer

B — Osmotic diuretic

Rationale

Mannitol is classified as an osmotic diuretic. It is a sugar alcohol that is freely filtered at the glomerulus but not reabsorbed by the renal tubule, creating an osmotic gradient that retains water in the tubular lumen and increases urine output. In neuroanesthesia, mannitol is used to reduce intracranial pressure by drawing free water from brain parenchyma into the plasma along an osmotic gradient, reducing brain water content and volume. Loop diuretics, such as furosemide, act at the thick ascending limb of the loop of Henle by inhibiting the sodium-potassium-chloride cotransporter. Thiazide diuretics act at the distal convoluted tubule. Carbonic anhydrase inhibitors, such as acetazolamide, reduce bicarbonate reabsorption in the proximal tubule — a distinct mechanism from osmotic diuresis.

Correct Answer

D — Glucocorticoid

Rationale

Dexamethasone is classified as a glucocorticoid. It is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties and negligible mineralocorticoid activity. In the neuroanesthesia context, dexamethasone is used to reduce vasogenic cerebral edema (swelling caused by disruption of the blood-brain barrier, as occurs around brain tumors and abscesses). Osmotic diuretics, such as mannitol, reduce intracranial pressure by a different mechanism — drawing free water from brain tissue into plasma. Mineralocorticoids, such as fludrocortisone, act primarily on sodium and potassium balance in the kidney. Alpha-2 adrenergic receptor agonists, such as dexmedetomidine, produce sedation and analgesia through a noradrenergic mechanism entirely distinct from the corticosteroid class.

Correct Answer

A — Isoflurane

Rationale

Isoflurane is the volatile agent most readily associated with burst suppression on electroencephalography (a pattern of alternating periods of electrical activity and silence reflecting profound neuronal suppression), producing this pattern at concentrations of approximately 1.5 to 2 minimum alveolar concentration. Burst suppression (minimum alveolar concentration — the alveolar concentration preventing purposeful movement in 50% of patients) represents the level of central nervous system suppression at which the brain's metabolic rate for oxygen is maximally reduced, a property sometimes exploited during neurosurgical procedures requiring brief vascular occlusion. Sevoflurane, desflurane, and halothane can produce electroencephalographic slowing and suppression at high concentrations but are not specifically identified with the burst suppression classification at the 1.5 to 2 minimum alveolar concentration range in the same way as isoflurane.

Correct Answer

C — Halothane

Rationale

Halothane produces the greatest increase in cerebral blood flow among the volatile anesthetic agents at equivalent doses. All volatile agents cause cerebral vasodilation and increase cerebral blood flow through direct action on cerebrovascular smooth muscle, but the magnitude differs: halothane produces the most pronounced cerebral vasodilation, while isoflurane and sevoflurane produce more modest increases. Desflurane is intermediate and similar to isoflurane. This property of halothane makes it the least favorable choice in patients with elevated intracranial pressure or reduced intracranial compliance, where even modest increases in intracranial blood volume can produce dangerous rises in intracranial pressure. Isoflurane and sevoflurane are therefore preferred when a volatile agent must be used in neurosurgical patients.

Correct Answer

B — Sevoflurane

Rationale

Sevoflurane does not sensitize the myocardium to catecholamine-induced arrhythmias. This property distinguishes it — along with isoflurane and desflurane — from halothane, which uniquely sensitizes the myocardium to catecholamines among the volatile agents. Catecholamine sensitization means that ventricular arrhythmias can be triggered by epinephrine at doses that would be safe under other anesthetic agents. Halothane is the only volatile halogenated agent with this property; it is one of the principal reasons halothane has been displaced by modern agents in high-resource settings. Enflurane does not cause catecholamine sensitization in the same clinically significant manner as halothane. Nitrous oxide also does not sensitize the myocardium to catecholamines. The key classification distinction is halothane versus all modern agents.

Correct Answer

D — Propofol

Rationale

Propofol is classified as preserving cerebral autoregulation better than volatile halogenated agents at clinical doses. Cerebral autoregulation is the ability of the cerebral vasculature to maintain relatively constant blood flow across a range of perfusion pressures. Volatile halogenated agents — including isoflurane, sevoflurane, halothane, and desflurane — impair cerebral autoregulation in a dose-dependent manner at concentrations of 1 minimum alveolar concentration or above, making cerebral blood flow increasingly dependent on mean arterial pressure. Propofol, by contrast, reduces cerebral blood flow and cerebral metabolic rate without the vasodilatory liability of volatile agents and better preserves autoregulatory capacity. This property is one rationale for preferring total intravenous anesthesia with propofol in patients with compromised intracranial compliance, such as those with mass lesions or traumatic brain injury.

Correct Answer

A — They reduce the cerebral metabolic rate for oxygen while simultaneously increasing cerebral blood flow through vasodilation

Rationale

Volatile anesthetic agents produce two simultaneous central nervous system effects that exist in clinical tension with each other. First, they reduce the cerebral metabolic rate for oxygen — a desirable property that decreases the brain's vulnerability to ischemic injury. Second, they cause cerebral vasodilation through direct action on cerebrovascular smooth muscle, increasing cerebral blood flow and intracranial blood volume. In patients with normal intracranial compliance, the modest rise in intracranial blood volume is easily compensated. In patients with reduced intracranial compliance — such as those with mass lesions, cerebral edema, or traumatic brain injury — the same vasodilation produces a disproportionate and potentially dangerous rise in intracranial pressure. Managing this tension — preserving the metabolic protection while controlling intracranial pressure — defines the challenge of neuroanesthesia. Volatile agents do not increase cerebral metabolic rate, cause primary cerebral vasoconstriction, or impair the blood-brain barrier directly.

Correct Answer

C — Hypocapnia (lowered arterial carbon dioxide)

Rationale

Hypocapnia — a reduction in arterial carbon dioxide partial pressure produced by hyperventilation — lowers the seizure threshold and potentiates enflurane's epileptogenic activity. In the presence of hypocapnia, enflurane can produce electroencephalographic spike-and-wave complexes and generalized tonic-clonic seizures at concentrations that might otherwise be subthreshold for overt seizure activity. This interaction is clinically important because controlled hyperventilation is sometimes used in neurosurgical anesthesia to reduce intracranial pressure — but when enflurane is the volatile agent, deliberate hypocapnia markedly increases seizure risk, making enflurane absolutely contraindicated in patients with seizure disorders and poorly suited for neurosurgical use. Hypercapnia raises the seizure threshold and does not potentiate enflurane's epileptogenic effect. Hypothermia generally suppresses neuronal excitability. Hyponatremia can lower seizure threshold independently but is not specifically identified as a potentiating factor for enflurane's epileptogenic activity.

Correct Answer

B — Cerebrospinal fluid bicarbonate adapts to the lower arterial carbon dioxide, restoring perivascular pH and reversing cerebral vasoconstriction

Rationale

Hyperventilation reduces intracranial pressure by lowering arterial carbon dioxide, which diffuses across the blood-brain barrier and causes a fall in perivascular pH around cerebral vessels. This pH change drives cerebral vasoconstriction, reducing intracranial blood volume and therefore intracranial pressure. Over 4 to 6 hours, however, cerebrospinal fluid bicarbonate concentration adapts by decreasing, which restores perivascular pH toward normal despite the continued low arterial carbon dioxide. As perivascular pH normalizes, the vasoconstrictive stimulus is removed and cerebral vasoconstriction reverses — intracranial pressure returns toward its pre-hyperventilation level. This adaptation means hyperventilation is most useful as an acute temporizing measure, not a sustained treatment for elevated intracranial pressure. Receptor downregulation does not explain this phenomenon — the mechanism is pH-mediated, not receptor-mediated. Cerebral metabolic rate does not increase compensatorily in this context. Renal bicarbonate excretion occurs over days to normalize blood pH in chronic respiratory alkalosis, not over the 4 to 6 hour window described.

Correct Answer

D — Halothane directly depresses sinoatrial node automaticity, while isoflurane reduces blood pressure through peripheral vasodilation that triggers a baroreceptor-mediated reflex increase in heart rate

Rationale

The mechanisms by which halothane and isoflurane reduce blood pressure are different, and this difference explains their opposite heart rate effects. Halothane reduces blood pressure primarily through direct myocardial depression — it decreases cardiac output by suppressing contractility and directly depresses sinoatrial node automaticity, producing bradycardia. Because the heart rate falls rather than rises, the cardiovascular depression from halothane is compounded. Isoflurane, by contrast, reduces blood pressure primarily through peripheral vasodilation, lowering systemic vascular resistance. The fall in blood pressure is sensed by baroreceptors, which trigger a compensatory reflex increase in heart rate via the sympathetic nervous system, partially maintaining cardiac output despite reduced afterload. This mechanism — peripheral vasodilation with reflex tachycardia — is shared by sevoflurane and desflurane at stable concentrations. Halothane does not block cardiac beta-1 adrenergic receptors as its primary mechanism. Halothane does not increase vagal tone centrally; it acts directly on the sinoatrial node. Halothane's sensitization of the myocardium to catecholamines is a separate phenomenon from its direct chronotropic depression.

Correct Answer

A — Cerebral blood flow becomes directly dependent on mean arterial pressure, so hypotension causes proportional reductions in cerebral blood flow

Rationale

Cerebral autoregulation is the mechanism by which cerebral vasculature maintains relatively constant blood flow across a range of mean arterial pressure (approximately 50 to 150 mmHg in healthy adults) by adjusting vascular resistance. When volatile agents impair autoregulation at concentrations of 1 minimum alveolar concentration or above, this active vascular adjustment is lost. Cerebral blood flow then varies passively and directly with mean arterial pressure — a state called pressure-passive flow. Under deep volatile anesthesia, a fall in mean arterial pressure produces a proportional fall in cerebral blood flow, increasing the risk of cerebral ischemia, while a rise in mean arterial pressure produces a proportional rise in cerebral blood flow and potentially elevated intracranial pressure. This is the opposite of the autoregulated state, where blood flow would remain constant across the same pressure changes. Maintaining mean arterial pressure within a range that supports adequate cerebral perfusion pressure is therefore a primary goal in neurosurgical anesthesia managed with volatile agents.

Correct Answer

C — Propofol reduces cerebral blood flow and cerebral metabolic rate without cerebral vasodilation and better preserves cerebral autoregulation than volatile agents

Rationale

Propofol has a favorable neurological profile for patients with elevated intracranial pressure for two related reasons. First, it reduces cerebral blood flow and cerebral metabolic rate without the cerebral vasodilation that all volatile halogenated agents produce — volatile agents increase intracranial blood volume through vasodilation, which can cause dangerous intracranial pressure elevations in patients with reduced intracranial compliance. Propofol avoids this liability. Second, propofol better preserves cerebrovascular coupling and cerebral autoregulation at clinical doses compared to volatile agents, which impair autoregulation in a dose-dependent fashion at concentrations of 1 minimum alveolar concentration or above. Together these properties make propofol the preferred agent for patients with mass lesions, cerebral edema, or traumatic brain injury. Propofol does not transiently raise intracranial pressure before lowering it. Propofol is not a cerebral vasodilator — the opposite is true. The speed of blood-brain barrier crossing is not the mechanism of propofol's neurological advantage.

Correct Answer

B — Mannitol creates an osmotic gradient in the plasma that draws free water from brain parenchyma into the vascular compartment; if the barrier is disrupted, mannitol enters the brain and equilibrates the gradient, abolishing the effect

Rationale

Mannitol reduces intracranial pressure by raising plasma osmolality. When mannitol is infused intravenously, it remains confined to the vascular compartment (because the intact blood-brain barrier prevents it from crossing into brain tissue) and creates a hypertonic plasma relative to the brain. Free water moves along this osmotic gradient from brain parenchyma into plasma, reducing brain water content and volume — and thereby reducing intracranial pressure. If the blood-brain barrier is disrupted (as in severe traumatic brain injury or areas of tumor necrosis), mannitol can cross into the brain tissue, equilibrating osmolality across the barrier and abolishing the osmotic gradient that drives water out. In these regions, mannitol loses its efficacy and may paradoxically worsen edema over time. Mannitol does not inhibit cerebrospinal fluid production at the choroid plexus — that is a mechanism of carbonic anhydrase inhibitors such as acetazolamide. Mannitol does not constrict cerebral blood vessels as its primary mechanism. Mannitol does not activate aquaporin channels; its action is a passive osmotic effect.

Correct Answer

D — Dexamethasone reduces vasogenic edema by decreasing blood-brain barrier permeability, but post-stroke cytotoxic edema results from intracellular swelling without barrier disruption and is unresponsive to this mechanism

Rationale

The two major types of cerebral edema have different mechanisms and different responses to dexamethasone. Vasogenic edema — which surrounds brain tumors and abscesses — results from disruption of the blood-brain barrier, allowing plasma proteins and fluid to leak into the brain interstitium. Dexamethasone reduces vasogenic edema by decreasing blood-brain barrier permeability, with onset over hours to days. Cytotoxic edema — which occurs after ischemic stroke and traumatic brain injury — results from failure of the adenosine triphosphate-dependent sodium-potassium pump in injured cells. When neurons and glia cannot maintain their ion gradients, sodium and water accumulate intracellularly, causing cellular swelling. The blood-brain barrier remains relatively intact in the early phase of cytotoxic edema, so dexamethasone's mechanism of reducing barrier permeability has no target and provides no benefit. Dexamethasone does not act by increasing renal sodium excretion — that is a mineralocorticoid mechanism. Dexamethasone's lack of efficacy in post-stroke edema is not due to rapid metabolism or absent neurons; it is a fundamental mismatch between drug mechanism and edema type.

Correct Answer

C — Isoflurane causes cerebral vasodilation, increasing intracranial blood volume; in a patient with reduced intracranial compliance from the tumor, the cranial vault cannot accommodate this increase, producing a disproportionate pressure rise

Rationale

The cranial vault is a rigid compartment of fixed total volume. Its contents — brain parenchyma, cerebrospinal fluid, and intracranial blood — must sum to a constant (the Monro-Kellie doctrine). Any increase in one component must be compensated by a decrease in another, or intracranial pressure rises. In a patient with normal intracranial compliance, compensatory mechanisms — such as displacement of cerebrospinal fluid into the spinal subarachnoid space — can buffer a modest increase in intracranial blood volume caused by volatile agent-induced vasodilation. In this patient, the large frontal glioblastoma has already consumed much of the available compensatory reserve, leaving reduced intracranial compliance. When isoflurane dilates cerebral vessels and increases intracranial blood volume, there is insufficient compliance to buffer the increase, and intracranial pressure rises steeply and dangerously — even at the same concentration that would cause only a modest, tolerable pressure change in a patient with normal intracranial compliance. This is why volatile agents should be used with caution in patients with mass lesions, and why concentrations should be kept at or below 1 minimum alveolar concentration with concurrent hyperventilation and propofol induction.

Correct Answer

A — Dexamethasone — it reduces vasogenic edema by decreasing blood-brain barrier permeability, but post-stroke edema is cytotoxic (intracellular swelling without barrier disruption) and does not respond to this mechanism

Rationale

Peritumoral cerebral edema is vasogenic in nature: the tumor disrupts the blood-brain barrier, allowing plasma proteins and fluid to leak into the brain interstitium. Dexamethasone reduces this edema by decreasing blood-brain barrier permeability, with onset over hours to days. It is the standard treatment for symptomatic peritumoral edema from brain tumors and abscesses. Post-stroke cerebral edema, by contrast, is primarily cytotoxic: failure of the adenosine triphosphate-dependent sodium-potassium pump in ischemic neurons causes intracellular accumulation of sodium and water, producing cellular swelling. Because the blood-brain barrier remains relatively intact in the early cytotoxic phase, dexamethasone's mechanism — reducing barrier permeability — has no target and provides no benefit. Multiple clinical trials have confirmed that dexamethasone does not improve outcomes in ischemic stroke and may worsen them. Mannitol can reduce intracranial pressure acutely in both tumor and stroke patients by osmotic dehydration of brain tissue, but it does not specifically reduce the edema surrounding a brain tumor and is not the preferred agent for this indication.

Correct Answer

D — Halothane directly depresses sinoatrial node automaticity causing bradycardia, while isoflurane reduces blood pressure through peripheral vasodilation that triggers a baroreceptor-mediated reflex increase in heart rate

Rationale

Although both halothane and isoflurane reduce mean arterial pressure, they do so through different mechanisms that produce opposite effects on heart rate. Halothane reduces blood pressure primarily through direct myocardial depression and direct suppression of sinoatrial node automaticity. Because the node's intrinsic firing rate is reduced, heart rate falls — the cardiovascular depression is not buffered by any compensatory tachycardia. Isoflurane, by contrast, reduces blood pressure mainly through peripheral vasodilation, lowering systemic vascular resistance. The fall in blood pressure is detected by arterial baroreceptors, which trigger a compensatory reflex sympathetic discharge that increases heart rate, partially maintaining cardiac output despite the lower afterload. This opposite pattern — bradycardia with halothane versus mild tachycardia with isoflurane — is a clinically important distinction that is particularly relevant when managing patients with impaired myocardial function, who tolerate direct depression and bradycardia poorly. Halothane does not sensitize the sinoatrial node to acetylcholine as its primary chronotropic mechanism. Halothane does not block cardiac beta-1 receptors. The baroreceptor reflex with isoflurane increases, not suppresses, heart rate.

Correct Answer

B — Propofol reduces cerebral blood flow and cerebral metabolic rate without cerebral vasodilation, and better preserves cerebral autoregulation than volatile agents

Rationale

In a patient with reduced intracranial compliance from a large meningioma with mass effect, even modest increases in intracranial blood volume can produce dangerous rises in intracranial pressure. Volatile halogenated agents cause cerebral vasodilation that increases intracranial blood volume — a liability that is clinically acceptable in patients with normal compliance but dangerous in this patient. Propofol avoids this problem: it reduces cerebral blood flow and cerebral metabolic rate through a mechanism that does not involve cerebral vasodilation, and it better preserves cerebrovascular coupling and cerebral autoregulation at clinical doses compared to volatile agents at 1 minimum alveolar concentration or above. Together, these properties make propofol the preferred anesthetic for patients with mass lesions and reduced intracranial compliance. While faster emergence is a real advantage of total intravenous anesthesia and is clinically valued after neurosurgery, it is not the mechanism that explains the preference for propofol in this patient with reduced intracranial compliance — the neurovascular profile is the primary rationale. Propofol has no direct antitumor or anti-inflammatory effect on meningioma cells.